CoChat

Variation in Precursor Lesions of Pancreatic Cancer among High-Risk Groups

Potjer, Thomas P., Schot, Ingrid, Langer, Peter, Heverhagen, Johannes T., Wasser, Martin N.J.M., Slater, Emily P., Klöppel, Günter, Morreau, Hans M., Bonsing, Bert A., de Vos tot Nederveen Cappel, Wouter H., Bargello, Mathias, Gress, Thomas M., Vasen, Hans F.A., Bartsch, Detlef K. · 2013 · Clinical Cancer Research
Cited by 67

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Purpose: Pancreatic ductal adenocarcinoma (PDAC) surveillance programs are currently offered to high-risk individuals aiming to detect precursor lesions or PDAC at an early stage. We assessed differences in frequency and behavior of precursor lesions and PDAC between two high-risk groups. Experimental Design: Individuals with a p16-Leiden germline mutation (N = 116; median age 54 years) and individuals from familial pancreatic cancer (FPC) families (N = 125; median age 47 years) were offered annual surveillance by MRI and magnetic resonance cholangiopancreatography (MRCP) with or without endoscopic ultrasound (EUS) for a median surveillance period of 34 months (0–127 months) or 36 months (0–110 months), respectively. Detailed information was collected on pancreatic cystic lesions detected on MRCP and precursor lesions in surgical specimens of patients who underwent pancreatic surgery. Results: Cystic lesions were more common in the FPC cohort (42% vs. 16% in p16-Leiden cohort), whereas PDAC was more common in the p16-Leiden cohort (7% vs. 0.8% in FPC cohort). Intraductal papillary mucinous neoplasm (IPMN) was a common finding in surgical specimens of FPC-individuals, and was only found in two patients of the p16-Leiden cohort. In the p16-Leiden cohort, a substantial proportion of cystic lesions showed growth or malignant transformation during follow-up, whereas in FPC individuals most cystic lesions remain stable. Conclusion: In p16-Leiden mutation carriers, cystic lesions have a higher malignant potential than in FPC-individuals. On the basis of these findings, a more intensive surveillance program may be considered in this high-risk group. Clin Cancer Res; 19(2); 442–9. ©2012 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-12-2730

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 67

Metadata

Authors
Potjer, T. P., Schot, I., Langer, P., Heverhagen, J. T., Wasser, M. N. J. M., Slater, E. P., Klöppel, G., Morreau, H. M., Bonsing, B. A., de Vos tot Nederveen Cappel, W. H., Bargello, M., Gress, T. M., Vasen, H. F. A., & Bartsch, D. K.
Venue
Clinical Cancer Research
Published
2013-01-15
Volume
19
Issue
2
Pages
442-449
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2070426735
Cited by
67
References
9
FWCI
1.14
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Variation in Precursor Lesions of Pancreatic Cancer among High-Risk Groups. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-12-2730
The paper
Potjer, T. P., Schot, I., Langer, P., Heverhagen, J. T., Wasser, M. N. J. M., Slater, E. P., Klöppel, G., Morreau, H. M., Bonsing, B. A., de Vos tot Nederveen Cappel, W. H., Bargello, M., Gress, T. M., Vasen, H. F. A., & Bartsch, D. K. (2013). Variation in Precursor Lesions of Pancreatic Cancer among High-Risk Groups. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-12-2730

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.